Implementation of risk-based lipid-lowering therapies in older (age ≥ 65 years) and very-old adults (age ≥ 75 years) with ischemic heart disease in the greater Salzburg region

Kristen Kopp; Lukas Motloch; B. Wernly; Alexander E. Berezin; Victoria Maringgele; Anna Dieplinger; Uta C. Hoppe; Michael Lichtenauer

doi:10.3389/fphar.2024.1357334

Implementation of risk-based lipid-lowering therapies in older (age ≥ 65 years) and very-old adults (age ≥ 75 years) with ischemic heart disease in the greater Salzburg region

Kristen Kopp, Lukas Motloch, B. Wernly, Alexander E. Berezin, Victoria Maringgele, Anna Dieplinger, Uta C. Hoppe, Michael Lichtenauer

Faculty of Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	1357334
Number of pages	1
Journal	Frontiers in Pharmacology
Volume	15
DOIs	https://doi.org/10.3389/fphar.2024.1357334
Publication status	Published - Jun 2024

Fields of science

303 Health Sciences
304 Medical Biotechnology
305 Other Human Medicine, Health Sciences
301 Medical-Theoretical Sciences, Pharmacy
302 Clinical Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3389/fphar.2024.1357334

Cite this

Kopp, K., Motloch, L., Wernly, B., Berezin, A. E., Maringgele, V., Dieplinger, A., Hoppe, U. C., & Lichtenauer, M. (2024). Implementation of risk-based lipid-lowering therapies in older (age ≥ 65 years) and very-old adults (age ≥ 75 years) with ischemic heart disease in the greater Salzburg region. Frontiers in Pharmacology, 15, Article 1357334. https://doi.org/10.3389/fphar.2024.1357334

@article{c07b4a5b457b4256a3a61747d7d3ad95,

title = "Implementation of risk-based lipid-lowering therapies in older (age ≥ 65 years) and very-old adults (age ≥ 75 years) with ischemic heart disease in the greater Salzburg region",

author = "Kristen Kopp and Lukas Motloch and B. Wernly and Berezin, \{Alexander E.\} and Victoria Maringgele and Anna Dieplinger and Hoppe, \{Uta C.\} and Michael Lichtenauer",

year = "2024",

month = jun,

doi = "10.3389/fphar.2024.1357334",

language = "English",

volume = "15",

journal = "Frontiers in Pharmacology",

issn = "1663-9812",

}

Kopp, K, Motloch, L, Wernly, B, Berezin, AE, Maringgele, V, Dieplinger, A, Hoppe, UC & Lichtenauer, M 2024, 'Implementation of risk-based lipid-lowering therapies in older (age ≥ 65 years) and very-old adults (age ≥ 75 years) with ischemic heart disease in the greater Salzburg region', Frontiers in Pharmacology, vol. 15, 1357334. https://doi.org/10.3389/fphar.2024.1357334

TY - JOUR

T1 - Implementation of risk-based lipid-lowering therapies in older (age ≥ 65 years) and very-old adults (age ≥ 75 years) with ischemic heart disease in the greater Salzburg region

AU - Kopp, Kristen

AU - Motloch, Lukas

AU - Wernly, B.

AU - Berezin, Alexander E.

AU - Maringgele, Victoria

AU - Dieplinger, Anna

AU - Hoppe, Uta C.

AU - Lichtenauer, Michael

PY - 2024/6

Y1 - 2024/6

UR - http://www.scopus.com/inward/record.url?scp=85197461112&partnerID=8YFLogxK

U2 - 10.3389/fphar.2024.1357334

DO - 10.3389/fphar.2024.1357334

M3 - Article

C2 - 38966548

SN - 1663-9812

VL - 15

JO - Frontiers in Pharmacology

JF - Frontiers in Pharmacology

M1 - 1357334

ER -

Implementation of risk-based lipid-lowering therapies in older (age ≥ 65 years) and very-old adults (age ≥ 75 years) with ischemic heart disease in the greater Salzburg region

Fields of science

UN SDGs

Access to Document

Other files and links

Cite this